
PROCEPT BioRobotics Corporation
- Jurisdiction
United States - ISIN
US74276L1052 (PRCT )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. Read full profile
Stock price
Fundamentals
- Net revenue
€235.38M - Gross margin
64.2% - EBIT
-€78.56M - EBIT margin
-33.4% - Net income
-€72.04M - Net margin
-30.6%
Statement period: - (published )
Estimates
Fiscal Year | Net revenue | Net income |
---|---|---|
|
| |
|
| |
|
|
Dividends
No dividend payouts
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
MOLL FREDERIC H | N/A |
|
|
|
|
Earnings Calls
Latest earnings call: May 1, 2024
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
Peter Brown |
|
|
|
Buy |
James Anderson |
|
|
|
Buy |